Dichotomous roles of leptin and adiponectin as enforcers against lipotoxicity during feast and famine

Molecular Biology of the Cell

Volumn 24, Issue 19, 2013, Pages 3011-3015

  Unger, Roger H ^a   Scherer, Philipp E ^a,b   Holland, William L ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; CYTOCHROME C OXIDASE; DIACYLGLYCEROL; FATTY ACID; FIBROBLAST GROWTH FACTOR 21; GLYCEROLIPID; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LEPTIN; LEPTIN RECEPTOR; LONG CHAIN FATTY ACID COENZYME A LIGASE; MEMBRANE PHOSPHOLIPID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; SPHINGOLIPID; SPHINGOMYELIN; THERMOZYMOCIDIN; TRIACYLGLYCEROL;

ADIPOCYTE; ADIPOSE TISSUE; ANTIDIABETIC ACTIVITY; APOPTOSIS; BIOTRANSFORMATION; CIRCADIAN RHYTHM; CONGESTIVE CARDIOMYOPATHY; DEACYLATION; DIABETES MELLITUS; ENDOCRINE FUNCTION; ENERGY EXPENDITURE; FAT INTAKE; FATTY ACID OXIDATION; HEART OUTPUT; HEART VENTRICLE HYPERTROPHY; HUMAN; HUNGER; INSULIN RESISTANCE; KETOGENIC DIET; LIPID OXIDATION; LIPID STORAGE; LIPOTOXICITY; NONHUMAN; OBESITY; ORGAN PRESERVATION; OVERNUTRITION; PATHOPHYSIOLOGY; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REPERFUSION INJURY; REVIEW; WEIGHT REDUCTION; WHITE ADIPOSE TISSUE;

ADIPOCYTES; ADIPONECTIN; ADIPOSE TISSUE; ANIMALS; ENERGY METABOLISM; FIBROBLAST GROWTH FACTORS; HOMEOSTASIS; LEPTIN; LIPID METABOLISM; STARVATION;

EID: 84884766837     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E12-10-0774     Document Type: Review

References (72)

1. Adams ACYC, Coskun T, Cheng C, Gimeno R, Luo Y, Kharitonenkov A (2012). The breadth of FGF21's metabolic actions are governed by FGFR1 in adipose tissue. Mol Metabol 2, 31-37.
2. Akasaka Y, Tsunoda M, Ogata T, Ide T, Murakami K (2010). Direct evidence for leptin-induced lipid oxidation independent of long-form leptin receptor. Biochim Biophys Acta 1801, 1115-1122.
3. Asterholm IW, Scherer PE (2010). Enhanced metabolic flexibility associated with elevated adiponectin levels. Am J Pathol 176, 1364-1376.
4. Badman MK, Pissios P, Kennedy AR, Koukos G, Flier JS, Maratos-Flier E (2007). Hepatic fibroblast growth factor 21 is regulated by PPARa and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metab 5, 426-437.
5. Chiu HC, Kovacs A, Ford DA, Hsu FF, Garcia R, Herrero P, Saffitz JE, Schaffer JE (2001). A novel mouse model of lipotoxic cardiomyopathy. J Clin Invest 107, 813-822.
6. Considine RV et al. (1996). Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334, 292-295.
7. Coskun T, Bina HA, Schneider MA, Dunbar JD, Hu CC, Chen Y, Moller DE, Kharitonenkov A (2008). Fibroblast growth factor 21 corrects obesity in mice. Endocrinology 149, 6018-6027.
8. Ding XB-MJ, Owen B, Bookout A, Colbert Coate K, Mangelsdorf D, Kliewer S (2012). βKlotho is required for fibroblast growth factor 21 effects on growth and metabolism. Cell Metab 15, 387-393.
9. Dutchak PA, Katafuchi T, Bookout AL, Choi JH, Yu RT, Mangelsdorf DJ, Kliewer SA (2012). Fibroblast growth factor-21 regulates PPAR? activity and the antidiabetic actions of thiazolidinediones. Cell 148, 556-567.
10. Fang X, Palanivel R, Cresser J, Schram K, Ganguly R, Thong FS, Tuinei J, Xu A, Abel ED, Sweeney G (2010). An APPL1-AMPK signaling axis mediates beneficial metabolic effects of adiponectin in the heart. Am J Physiol Endocrinol Metabol 299, E721-E729.
11. Fisher FM et al. (2012). FGF21 regulates PGC-1a and browning of white adipose tissues in adaptive thermogenesis. Genes Dev 26, 271-281.
12. Fontes G, Semache M, Hagman DK, Tremblay C, Shah R, Rhodes CJ, Rutter J, Poitout V (2009). Involvement of Per-Arnt-Sim Kinase and extracellular-regulated kinases-1/2 in palmitate inhibition of insulin gene expression in pancreatic β-cells. Diabetes 58, 2048-2058.
13. Frederich RC, Hamann A, Anderson S, Lollmann B, Lowell BB, Flier JS (1995). Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat Med 1, 1311-1314.
14. Hagman DK, Hays LB, Parazzoli SD, Poitout V (2005). Palmitate inhibits insulin gene expression by altering PDX-1 nuclear localization and reducing MafA expression in isolated rat islets of Langerhans. J Biol Chem 280, 32413-32418.
15. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM (1995). Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269, 543-546.
16. Holland WL et al. (2013). An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice. Cell Metab 17, 790-797.
17. Holland WL et al. (2011). Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin. Nat Med 17, 55-63.
18. Holland WL, Summers SA (2008). Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism. Endocr Rev 29, 381-402.
19. Ikeda Y, Ohashi K, Shibata R, Pimentel DR, Kihara S, Ouchi N, Walsh K (2008). Cyclooxygenase-2 induction by adiponectin is regulated by a sphingosine kinase-1 dependent mechanism in cardiac myocytes. FEBS Lett 582, 1147-1150.
20. Inagaki T et al. (2007). Endocrine regulation of the fasting response by PPARa-mediated induction of fibroblast growth factor 21. Cell Metab 5, 415-425.
21. Kharitonenkov A et al. (2005). FGF-21 as a novel metabolic regulator. J Clin Invest 115, 1627-1635.
22. Kim JY et al. (2007). Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J Clin Invest 117, 2621-2637.
23. Kubota N et al. (2006). Pioglitazone ameliorates insulin resistance and diabetes by both adiponectin-dependent and -independent pathways. J Biol Chem 281, 8748-8755.
24. Lee Y, Naseem RH, Duplomb L, Park BH, Garry DJ, Richardson JA, Schaffer JE, Unger RH (2004). Hyperleptinemia prevents lipotoxic cardiomyopathy in acyl CoA synthase transgenic mice. Proc Natl Acad Sci USA 101, 13624-13629.
25. Lin Z et al. (2013). Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice. Cell Metab 17, 779-789.
26. Mazumder PK, O'Neill BT, Roberts MW, Buchanan J, Yun UJ, Cooksey RC, Boudina S, Abel ED (2004). Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob/ob mouse hearts. Diabetes 53, 2366-2374.
27. Minokoshi Y, Kim YB, Peroni OD, Fryer LG, Muller C, Carling D, Kahn BB (2002). Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 415, 339-343.
28. Miyazaki S, Izawa T, Ogasawara JE, Sakurai T, Nomura S, Kizaki T, Ohno H, Komabayashi T (2010). Effect of exercise training on adipocyte-size-dependent expression of leptin and adiponectin. Life Sci 86, 691-698.
29. Nawrocki AR et al. (2006). Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonists. J Biol Chem 281, 2654-2660.
30. Nishimura T, Nakatake Y, Konishi M, Itoh N (2000). Identification of a novel FGF, FGF-21, preferentially expressed in the liver. Biochim Biophys Acta 1492, 203-206.
31. Palanivel R, Eguchi M, Shuralyova I, Coe I, Sweeney G (2006). Distinct effects of short- and long-term leptin treatment on glucose and fatty acid uptake and metabolism in HL-1 cardiomyocytes. Metabolism 55, 1067-1075.
32. Park BH, Wang MY, Lee Y, Yu X, Ravazzola M, Orci L, Unger RH (2006). Combined leptin actions on adipose tissue and hypothalamus are required to deplete adipocyte fat in lean rats: implications for obesity treatment. J Biol Chem 281, 40283-40291.
33. Park TS et al. (2008). Ceramide is a cardiotoxin in lipotoxic cardiomyopathy. J Lipid Res 49, 2101-2112.
34. Adams ACYC, Coskun T, Cheng C, Gimeno R, Luo Y, Kharitonenkov A (2012). The breadth of FGF21's metabolic actions are governed by FGFR1 in adipose tissue. Mol Metabol 2, 31-37.
35. Akasaka Y, Tsunoda M, Ogata T, Ide T, Murakami K (2010). Direct evidence for leptin-induced lipid oxidation independent of long-form leptin receptor. Biochim Biophys Acta 1801, 1115-1122.
36. Asterholm IW, Scherer PE (2010). Enhanced metabolic flexibility associated with elevated adiponectin levels. Am J Pathol 176, 1364-1376.
37. Badman MK, Pissios P, Kennedy AR, Koukos G, Flier JS, Maratos-Flier E (2007). Hepatic fibroblast growth factor 21 is regulated by PPARa and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metab 5, 426-437.
38. Chiu HC, Kovacs A, Ford DA, Hsu FF, Garcia R, Herrero P, Saffitz JE, Schaffer JE (2001). A novel mouse model of lipotoxic cardiomyopathy. J Clin Invest 107, 813-822.
39. Considine RV et al. (1996). Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334, 292-295.
40. Coskun T, Bina HA, Schneider MA, Dunbar JD, Hu CC, Chen Y, Moller DE, Kharitonenkov A (2008). Fibroblast growth factor 21 corrects obesity in mice. Endocrinology 149, 6018-6027.
41. Ding XB-MJ, Owen B, Bookout A, Colbert Coate K, Mangelsdorf D, Kliewer S (2012). βKlotho is required for fibroblast growth factor 21 effects on growth and metabolism. Cell Metab 15, 387-393.
42. Dutchak PA, Katafuchi T, Bookout AL, Choi JH, Yu RT, Mangelsdorf DJ, Kliewer SA (2012). Fibroblast growth factor-21 regulates PPAR? activity and the antidiabetic actions of thiazolidinediones. Cell 148, 556-567.
43. Fang X, Palanivel R, Cresser J, Schram K, Ganguly R, Thong FS, Tuinei J, Xu A, Abel ED, Sweeney G (2010). An APPL1-AMPK signaling axis mediates beneficial metabolic effects of adiponectin in the heart. Am J Physiol Endocrinol Metabol 299, E721-E729.
44. Fisher FM et al. (2012). FGF21 regulates PGC-1a and browning of white adipose tissues in adaptive thermogenesis. Genes Dev 26, 271-281.
45. Fontes G, Semache M, Hagman DK, Tremblay C, Shah R, Rhodes CJ, Rutter J, Poitout V (2009). Involvement of Per-Arnt-Sim Kinase and extracellular-regulated kinases-1/2 in palmitate inhibition of insulin gene expression in pancreatic β-cells. Diabetes 58, 2048-2058.
46. Frederich RC, Hamann A, Anderson S, Lollmann B, Lowell BB, Flier JS (1995). Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat Med 1, 1311-1314.
47. Hagman DK, Hays LB, Parazzoli SD, Poitout V (2005). Palmitate inhibits insulin gene expression by altering PDX-1 nuclear localization and reducing MafA expression in isolated rat islets of Langerhans. J Biol Chem 280, 32413-32418.
48. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM (1995). Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269, 543-546.
49. Holland WL et al. (2013). An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice. Cell Metab 17, 790-797.
50. Holland WL et al. (2011). Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin. Nat Med 17, 55-63.
51. Holland WL, Summers SA (2008). Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingo-lipid metabolism. Endocr Rev 29, 381-402.
52. Ikeda Y, Ohashi K, Shibata R, Pimentel DR, Kihara S, Ouchi N, Walsh K (2008). Cyclooxygenase-2 induction by adiponectin is regulated by a sphingosine kinase-1 dependent mechanism in cardiac myocytes. FEBS Lett 582, 1147-1150.
53. Inagaki T et al. (2007). Endocrine regulation of the fasting response by PPARa-mediated induction of fibroblast growth factor 21. Cell Metab 5, 415-425.
54. Kharitonenkov A et al. (2005). FGF-21 as a novel metabolic regulator. J Clin Invest 115, 1627-1635.
55. Kim JY et al. (2007). Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J Clin Invest 117, 2621-2637.
56. Kubota N et al. (2006). Pioglitazone ameliorates insulin resistance and diabetes by both adiponectin-dependent and -independent pathways. J Biol Chem 281, 8748-8755.
57. Lee Y, Naseem RH, Duplomb L, Park BH, Garry DJ, Richardson JA, Schaffer JE, Unger RH (2004). Hyperleptinemia prevents lipotoxic cardiomyopathy in acyl CoA synthase transgenic mice. Proc Natl Acad Sci USA 101, 13624-13629.
58. Lin Z et al. (2013). Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice. Cell Metab 17, 779-789.
59. Mazumder PK, O'Neill BT, Roberts MW, Buchanan J, Yun UJ, Cooksey RC, Boudina S, Abel ED (2004). Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob/ob mouse hearts. Diabetes 53, 2366-2374.
60. Minokoshi Y, Kim YB, Peroni OD, Fryer LG, Muller C, Carling D, Kahn BB (2002). Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 415, 339-343.
61. Miyazaki S, Izawa T, Ogasawara JE, Sakurai T, Nomura S, Kizaki T, Ohno H, Komabayashi T (2010). Effect of exercise training on adipocyte-size-dependent expression of leptin and adiponectin. Life Sci 86, 691-698.
62. Nawrocki AR et al. (2006). Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonists. J Biol Chem 281, 2654-2660.
63. Nishimura T, Nakatake Y, Konishi M, Itoh N (2000). Identification of a novel FGF, FGF-21, preferentially expressed in the liver. Biochim Biophys Acta 1492, 203-206.
64. Palanivel R, Eguchi M, Shuralyova I, Coe I, Sweeney G (2006). Distinct effects of short- and long-term leptin treatment on glucose and fatty acid uptake and metabolism in HL-1 cardiomyocytes. Metabolism 55, 1067-1075.
65. Park BH, Wang MY, Lee Y, Yu X, Ravazzola M, Orci L, Unger RH (2006). Combined leptin actions on adipose tissue and hypothalamus are required to deplete adipocyte fat in lean rats: implications for obesity treatment. J Biol Chem 281, 40283-40291.
66. Park TS et al. (2008). Ceramide is a cardiotoxin in lipotoxic cardiomyopathy. J Lipid Res 49, 2101-2112.
67. Shimabukuro M, Wang MY, Zhou YT, Newgard CB, Unger RH (1998). Protection against lipoapoptosis of β cells through leptin-dependent maintenance of Bcl-2 expression. Proc Natl Acad Sci USA 95, 9558-9561.
68. Sun K, Halberg N, Khan M, Magalang UJ, Scherer PE (2013). Selective inhibition of hypoxia-inducible factor 1a ameliorates adipose tissue dysfunction. Mol Cell Biol 33, 904-917.
69. Unger RH (2002). Lipotoxic diseases. Annu Rev Med 53, 319-336.
70. Veniant MM, Hale C, Helmering J, Chen MM, Stanislaus S, Busby J, Vonderfecht S, Xu J, Lloyd DJ (2012). FGF21 promotes metabolic homeostasis via white adipose and leptin in mice. PloS One 7, e40164.
71. Yagyu H et al. (2003). Lipoprotein lipase (LpL) on the surface of cardiomyocytes increases lipid uptake and produces a cardiomyopathy. J Clin Invest 111, 419-426.
72. Yamauchi T et al. (2001). The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7, 941-946.